Screening for skin cancer: Absence of evidence

Archives of Dermatology

Volumn 145, Issue 8, 2009, Pages 926-927

  Federman, Daniel G ^a   Concato, John ^b   Kirsner, Robert S ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; DERMATOLOGY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EDITORIAL; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; KERATINOCYTE; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SKIN CANCER; SKIN DEFECT; SKIN EXAMINATION; SQUAMOUS CELL CARCINOMA; URINE INCONTINENCE; VETERAN;

EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MASS SCREENING; MELANOMA; PHYSICAL EXAMINATION; SELF-EXAMINATION; SKIN NEOPLASMS;

EID: 68949101912     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.130     Document Type: Editorial

References (25)

1. U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(3):188-193.
2. Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;150(3):194-198.
3. Kantor J, Kantor DE. Routine dermatologist-performed full-body skin examination and early melanoma detection. Arch Dermatol. 2009;145(8):873-876.
4. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
5. Geller AC, Miller DR, Swetter SM, Demierre MF, Gilchrest BA. A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol. 2006;142(4):504-507.
6. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97(3):195-199.
7. Elwood JM. Screening for melanoma and options for its evaluation. J Med Screen. 1994;1(1):22-38.
8. Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring IT. A randomized trial of population screening for melanoma. J Med Screen. 2002;9(1):33-37.
9. Lowe JB, Ball J, Lynch JB, et al. Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot Int. 2004;19(4):437-444.
10. Carli P, De Giorgi V, Palli D, et al. Dermatologist detection and skin self-examination are associated with thinner melanomas. Arch Dermatol. 2003;139(5):607-612.
11. Federman DG, Kravetz JD, Tobin DG, Ma F, Kirsner RS. Full body skin examinations: the patient's perspective. Arch Dermatol. 2004;140(5):530-534.
12. Federman DG, Kravetz JD, Ma F, Kirsner RS. Patient gender affects skin cancer screening practices and attitudes among veterans. South Med J. 2008;101(5):513-518.
13. Rodriguez GL, Ma F, Federman DG, et al. Predictors of skin cancer screening practice and attitudes in primary care. J Am Acad Dermatol. 2007;57(5):775-781.
14. Federman DG, Reid C, Feldman SR, Greenhoe J, Kirsner RS. The primary care provider and the care of skin disease. Arch Dermatol. 2001;137(1):25-29.
15. Federman DG, Concato J, Kirsner RS. Comparison of dermatologic diagnoses by primary care practitioners and dermatologists: a review of the literature. Arch Fam Med. 1999;8(2):170-172.
16. Kirsner RS, Federman DG. Lack of correlation between internists' ability in dermatology and their patterns of treating patients with skin disease. Arch Dermatol. 1996;132(9):1043-1046.
17. Chen SC, Bravata DM, Weil E, Olkin I. A comparison of dermatologists' and primary care physicians' accuracy in diagnosing melanoma: a systematic review. Arch Dermatol. 2001;137(12):1627-1634.
18. Kirsner RS, Muhkerjee S, Federman DG. Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol. 1999;41(4):564-566.
19. Geller AC, O'Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC. Overcoming obstacles to skin cancer examinations and prevention counseling for high risk patients. J Am Board Fam Pract. 2004;17(6):416-423.
20. Federman DG, Kravetz JD, Kirsner RS. Skin cancer screening by dermatologists: prevalence and barriers. J Am Acad Dermatol. 2002;46(5):710-714.
21. Concato J, Horwitz RI. Beyond randomised versus observational studies. Lancet. 2004;363(9422):1660-1661.
22. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887-1892.
23. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653-657.
24. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342(25):1878-1886.
25. Concato J. What will the emperor say? screening for prostate cancer as of 2008. Cancer J. 2009;15(1):7-12.